Published On: 10/29/2024
DIA RWE 2024 Research: Presentation by David Pritchard, PhD
Target RWE Director of Data Management & Statistics, David Pritchard, PhD, recently provided an insightful video preview of his presentation at the DIA Real-World Evidence (RWE) Conference titled 'Making the Case for Negative Control Outcome Studies in a Real-World Evidence Setting.' In this session, Dr. Pritchard delves into using Negative Control Outcome studies (NCOs) as a methodological approach to ensure robust treatment group comparability, ultimately strengthening study validity and reliability in real-world research settings.
Watch the video below to gain a deeper understanding of how NCO studies can enhance the accuracy of your research, reduce bias, and elevate the overall quality of your study findings.
About Target RWE
Target RWE generates real-world evidence (RWE) that informs strategic decisions across the drug development lifecycle. Our unique combination of clinical, analytical and technical expertise enables comprehensive insight generation from complete retrospective and prospective longitudinal patient journeys, with unparalleled scale and accuracy.
Visit our website to learn more: https://targetrwe.com/
Contact:
McKinley Peter
Digital Marketing Specialist
+1 (352) 514-8045
More News
-
12/09/2025
Target RWE Announces Appointment of Alan Brookhart as President of NoviSci at Target RWE -
11/25/2025
Real-World Evidence [RWE] Demonstrates Repatha’s Long-Term Cardiovascular Benefits -
11/04/2025
Target RWE Appoints Sriram Krishnan as New Chief Product Officer -
08/21/2025
Target RWE Presenting at ISPE 2025: Powering Evidence Generation with Causal Inference -
06/24/2025
Target RWE Advances Next-Generation Causal Inference Approaches in Real-World Evidence with New Publications